蒙特卢卡斯特对性结肠炎患者缓解维持的影响:一项随机,双盲控制的临床试验
Kourosh Masnadi Shirazi1, Mehran Nezam Diba1, Arman Masnadi Shirazinezhad2
1Liver and Gastrointestinal Diseases Research Center, Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.
BMC gastroenterology
|March 6, 2025
概括
蒙特卢卡斯特在类固醇缓解期间显著改善了性结肠炎 (UC) 患者的缓解维持. 这项研究发现,与安慰剂相比,蒙特卢卡斯特治疗的无复发期更长,炎症标志物减少.
科学领域:
- 胃肠病学 胃肠病学
- 临床药理学 临床药理学
- 炎症研究 炎症研究
背景情况:
- 胰岛素在炎症途径中起作用.
- 蒙特卢卡斯特表现出抗 leukotriene 的作用.
- 性结肠炎 (UC) 是一种炎症性肠病.
研究的目的:
- 评估蒙特卢卡斯特在维持性结肠炎患者缓解的疗效.
- 评估蒙特卢卡斯特在UC患者的皮质类固醇减缓阶段的影响.
主要方法:
- 这是一项双盲,随机对照试验,涉及222名UC患者.
- 患者接受了10毫克蒙特卢卡斯特或安慰剂22周,同时服用普雷迪尼索隆剂量逐渐减少.
- 随访延长了干预后的八周.
主要成果:
- 蒙特卢卡斯特显著增加了无复发期 (27.25周对20.88周,P<0.001).
- 在蒙特卢卡斯特组中观察到较低的部分梅奥得分和炎症生物标志物.
- 与安慰剂相比,蒙特卢卡斯特组中较少的患者有高便calprotectin水平.
结论:
- 蒙特卢卡斯特在接受类固醇缓和治疗的UC患者中显示出对缓解维持的显著积极作用.
- 这些发现支持蒙特卢卡斯特作为UC缓解维护的潜在辅助疗法.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
219
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
219
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
211
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
211
Drugs for Treatment of Ulcerative Colitis in IBD
116
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
116
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
92
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
92
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
190
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
190
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
130
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
130


